Hui Xu

ORCID: 0000-0002-4904-5459 · 19 papers in corpus · active 2006-2025

Study types

  • article 11
  • other 6
  • book-chapter 2

Condition tags

  • endometriosis 14
  • mesh:D004715 8
  • adenomyosis 2
  • dyspareunia 1
  • infertility 1
  • dysmenorrhea 1
  • endometrioma 1
other 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1741271

[This corrects the article DOI: 10.3389/fimmu.2021.641206.].

article 2025
International immunopharmacology ·doi:10.1016/j.intimp.2025.115894
article 2025
Minerva medica ·doi:10.23736/s0026-4806.25.09186-4
article 2024
·doi:10.1111/jog.16135

OBJECTIVE: Thin endometrium caused by various factors affects the conception rate of females worldwide; however, current medications are still insufficient. Therefore, a novel approach is needed. We previously reported the effect of menstru…

article 2024
Quantitative imaging in medicine and surgery ·doi:10.21037/qims-23-1621

Background: Accurate preoperative diagnosis of endometrial cancer (EC) with deep myometrial invasion (DMI) is critical to deciding whether to perform lymphadenectomy. However, the presence of adenomyosis makes distinguishing DMI from superf…

other 2024
Cell death discovery ·doi:10.1038/s41420-024-02229-3

Endometriosis, an estrogen-dependent chronic inflammatory condition, afflicts reproductive-aged women. However, the underlying pathological mechanisms remain to be elucidated. Nicotinamide N-methyltransferase (NNMT) is a critical enzyme inv…

other 2024
Genes & diseases ·doi:10.1016/j.gendis.2023.101166
article 2022
Frontiers in immunology ·doi:10.3389/fimmu.2022.986202

Endometriosis is an estrogen-dependent gynecological disease with chronic pelvic inflammation. In order to study the pathophysiology of endometriosis and examine the therapeutic effects of new pharmaceuticals for endometriosis treatment, di…

book-chapter 2021
·doi:10.1016/b978-0-12-820661-4.00001-7
article 2021
Frontiers in immunology ·doi:10.3389/fimmu.2021.641206

Endometriosis is a common, benign, and hormone-dependent gynaecological disorder that displays altered immunoinflammatory profiles. Myeloid-derived suppressor cells (MDSCs) suppressed immunosurveillance in endometriosis in human and mouse m…

other 2018
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-018-0347-9

BACKGROUND: Current medical treatments for endometriosis are very limited. Progestin and selective progesterone receptor modulators (SPRM) are developed but their efficacy, safety, mechanism and recurrence in endometriosis are not fully stu…

article 2013
Angiogenesis ·doi:10.1007/s10456-013-9333-1
book-chapter 2012
·doi:10.5772/28874

Endometriosis is a common gynaecological disease, defined by the presence of endometrial tissue outside the uterus, causing pain and infertility of women in reproductive age (Galle, 1989). It is estimated that it occurs in 10-15% for women …

other 2012
article 2012
Angiogenesis ·doi:10.1007/s10456-012-9299-4
other 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.07.008

OBJECTIVE: To investigate the antiangiogenesis mechanism of epigallocatechin-3-gallate (EGCG) in an endometriosis model in vivo. DESIGN: Animal studies. SETTING: University laboratory. ANIMAL(S): Human endometrium from women with endomet…

article 2009

Objective:To explore the value of transvaginal ultrasonography in diagnosing ovarian endometriotic cysts(OEC).Methods:To review and analysis the characteristics of sonograms of 62 ovary massin 54 cases of OEC,and compare with the result of …

article 2008
Human Reproduction ·doi:10.1093/humrep/den417

BACKGROUND: The development of new blood vessels plays an essential role in growth and survival of endometriosis. Epigallocatechin gallate (EGCG) from green tea has powerful anti-angiogenic properties and our aim was to evaluate these prope…

article 2006

Objective To explore the effect of mifepristone on expression of survivin in endometriotic rats. Methods Endometriotic rats were randomly divided into control group and mifepristone group (including low-dose and high -dose groups). 4 weeks …